Antiphospholipid Syndrome Antiphospholipid antibodies can induce endothelial-cell,
complement, platelet, neutrophil, and monocyte activation, leading to thrombosis, renal …

The antiphospholipid (antibody) syndrome (APS) is an autoimmune condition characterised
by a wide range of clinical features, but primarily identified as thrombotic and/or obstetric …

Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disease characterized
by thrombosis and/or pregnancy complications caused by antiphospholipid antibodies …

The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or
pregnancy morbidity in combination with the persistent presence of circulating …

The latest consensus “guidelines” outlining revised Classification Criteria for
antiphospholipid syndrome (APS) has just been published. 1 The aim of this publication was …

The antiphospholipid syndrome (APS) is diagnosed by the combination of vascular
thrombosis and/or pregnancy morbidity and the detection of antiphospholipid antibodies …

A debate on updating the laboratory criteria of antiphospholipid syndrome (APS) was
recently opened in view to lower the risk of over diagnosis of the syndrome. Based on data …

OBJECTIVE: We carried out a prospective analysis of clinical and analytical findings in
individuals with antiphospholipid antibodies (aPL). METHODS: We prospectively studied …

The antiphospholipid antibody syndrome (APS) is recognized as a major cause of acquired
thrombophilia and recurrent pregnancy morbidity. 6, 9, 11, 12, 19 It can either occur as a free …

The international classification criteria for definite antiphospholipid syndrome (APS) include
three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti …